Case-by-Case Study
Profiling Adequan® Canine
(polysulfated glycosaminoglycan)
Discover how four dogs are effectively managing
their osteoarthritis (OA) challenges.
Case-by-Case Study
Profiling Adequan® Canine
(polysulfated glycosaminoglycan)
Discover how four dogs are effectively managing
their osteoarthritis (OA) challenges.
Discover if Adequan® Canine is right for your patients and please see Important Safety Information below the course description.
RACE-Approved 0.5 Hour CE Course
Meet the Presenter
Dr. Julia Tomlinson
Julia Tomlinson, BVSc, MS, PhD, DACVS, CCRP, CVSMT, DACVSMR, Owner, Twin Cities Animal Rehabilitation and Sports Medicine, Burnsville, Minnesota.
Dr. Julia Tomlinson is a board-certified specialist in rehabilitation and sports medicine and was the first such canine specialist in the state of Minnesota.
Read Dr. Tomlinson’s Full Bio >
Dr. Julia Tomlinson
Julia Tomlinson, BVSc, MS, PhD, DACVS, CCRP, CVSMT, DACVSMR, Owner, Twin Cities Animal Rehabilitation and Sports Medicine, Burnsville, Minnesota.
Dr. Julia Tomlinson is a board-certified specialist in rehabilitation and sports medicine and was the first such canine specialist in the state of Minnesota.
Read Dr. Tomlinson’s Full Bio >
Dr. Julia Tomlinson
Julia Tomlinson, BVSc, MS, PhD, DACVS, CCRP, CVSMT, DACVSMR, Owner, Twin Cities Animal Rehabilitation and Sports Medicine, Burnsville, Minnesota.
Dr. Julia Tomlinson is a board-certified specialist in rehabilitation and sports medicine and was the first such canine specialist in the state of Minnesota.
Read Dr. Tomlinson’s Full Bio >
Course Overview
Dr. Julia Tomlinson provides valuable insights on the benefits of identifying osteoarthritis (OA) early in the chronology of clinical signs that dogs experience with this progressive disease. She identifies the importance of treating all clinical signs, both early in the OA disease cycle, and throughout the five disease stages, to help support joint health while aiding joint recovery. This CE course will help you gain a better appreciation for the overall spectrum of OA treatment and management, such as pharmaceuticals, activity modification, home environment and exercise. Dr. Tomlinson reaffirms the powerful opportunity of engaging in mobility-related conversations and explaining the pathogenesis of the disease to clients before dogs are diagnosed with OA, especially for those with predisposed breeds. Dr. Tomlinson also delivers practical tips for offering curbside OA appointments, utilizing the entire veterinary team and partnering with rehabilitation veterinary specialists to help pet owners and their dogs enjoy a lifetime of everyday adventures.
Adequan® Canine polysulfated glycosaminoglycan (PSGAG)
Indications and Usage
Adequan® Canine is recommended for intramuscular injection for the control of signs associated with non-infectious degenerative and/or traumatic arthritis of canine synovial joints.
IMPORTANT SAFETY INFORMATION
Adequan® Canine should not be used in dogs who are hypersensitive to PSGAG or who have a known or suspected bleeding disorder. It should be used with caution in dogs with renal or hepatic impairment. Adverse reactions in clinical studies (transient pain at injection site, transient diarrhea, and abnormal bleeding) were mild and self-limiting. In post approval experience, death has been reported in some cases; vomiting, anorexia, depression/lethargy and diarrhea have also been reported. The safe use of PSGAG in breeding, pregnant or lactating dogs has not been evaluated. Caution: Federal law restricts this drug to use by or on the order of a licensed veterinarian. For additional safety information, please see full prescribing information at adequancanine.com.
Learn the basic effects of canine osteoarthritis (OA) and the strength of treating the disease early.
All trademarks are the property of American Regent, Inc.
5 Ramsey Road, Shirley, NY 11967 | 1-800-458-0163 | cs@americanregent.com
© 2023, American Regent, Inc. PP-AC-US-0568